Introduction 38
Management of large bone defects resulting from trauma, infection, or tumor 39 resection remains a major clinical challenge for orthopaedic surgeons [1] [2] [3] . These defects 40 are considered critical bone defects if they are unlikely to heal spontaneously during a 41 patient's lifetime and are typically larger than twice the width of the diaphysis 4 . The gold 42 standard for treatment is the use of autologous bone graft; however, due to the associated 43 morbidity and lack of adequate bone stock or donor sites, alternative grafts are commonly 44 used. The ideal bone graft is osteoconductive, osteogenic, and osteoinductive 1 . 45 Osteoconductivity is the ability for the bone graft to allow osseous growth on the surface, 46 or within its pores 5 . Osteogenic grafts retain living bone cells 5 . Osteoinductivity is the 47 ability to stimulate progenitor cells to differentiate into a bone forming cell lineage 5,6 . 48 Alternative bone grafts include allografts and tissue engineered bone substitutes 1,4 . 49 Allograft use risks disease transmission and has limited availability from young, healthy 50 donors 7, 8 . Tissue engineered constructs include synthetics and xenograft-derived 51 alternatives 4 . The advantage of synthetic bone replacements is that the constructs can be 52 manufactured to custom structure 9 . Furthermore, osteogenicity can be artificially re-53 created by pre-seeding osteogenic cells onto the material prior to implantation. 54 Osteoinductivity, however, requires the construct be able to induce cell differentiation, 55 and therefore is more difficult to re-create 6, 10, 11 . Xenografts are one potential way to 56 utilize the natural osteoinductive properties of native bone without using an allograft. 57
Swine may be the ideal species for xenotransplantation due to physiologic compatibility 58 with humans 12, 13 . However; porcine xenotransplantation is potentially dangerous due to 59 the presence of the alpha-gal epitope which can induce a severe inflammatory response in 60 human hosts 14, 15 . Our laboratory developed a novel decellularization process that 61 successfully renders porcine soft tissues sterile and removes the alpha-gal epitope [16] [17] [18] [19] . 62
We have applied this process to porcine cancellous bone and demonstrated that the 63 construct was successfully decellularized and maintained native structural properties, 64 therefore preserving the construct's osteoconductivity 19, 20 . Proteomics data also showed 65 that important growth factors believed to have a critical role in cell differentiation and 66 osteoinductivity were also preserved on the scaffold. However, the clinical relevance and 67 biologic function of these proteins after chemical processing are unknown. 68 Therefore, the current research project aimed to: 69 1) Demonstrate osteoinductive potential of a porcine xenograft-derived bone 70 scaffold in vitro. 71
2) Prove the osteoinductive potential is maintained in an in vivo model. 72
Materials and Methods 73
In vitro and in vivo experiments were designed to determine if a novel 74 decellularization and oxidation protocol applied to porcine bone resulted in an 75 osteoinductive bone scaffold. Scaffolds were processed using methods previously 76 described 17 . Briefly, cancellous bone was harvested from the distal metaphysis of 77 porcine femurs collected from an abattoir and subjected to a chemical decellularization 78 and oxidation protocol using combinations of deionized water, trypsin, antimicrobials, 79 peracetic acid, and triton X-100. Residual peracetic acid was cleared from specimens by 80 serial water washes until PAA levels were below the limits of detection (0.5 parts per 81 million) with high sensitivity PAA test strips (Quantofix® peroxides test sticks, Sigma). 82 Scaffolds were lyophilized and frozen at -80 o C until further use. Previous proteomics 83 experiments by our group have demonstrated that following this process the protein 84 composition of the scaffold is similar to that of a commercial DBM product 19 Mass 85 spectrometry demonstrated that in addition to the expected abundance of structural 86 proteins, such as collagen alpha-1 and -2 chains, there were also notable similarities in 87 the growth factors preserved on the scaffold and commercial DBM samples analyzed. 88
Proteins such as chondroadherin, lumican, fibromodulin and biglycan play critical roles 89 in cell differentiation, intra-cellular cascade signaling, and extra-cellular matrix assembly, 90 and were found on both the porcine scaffold and human DBM. 91
Two different cell lines were chosen for indirect quantification of the scaffold's 92 osteoinductive potential. C2C12 (ATCC ® CRL1772™, Rockville, MD) is a mouse 93 myoblast cell line that differentiates into osteoblasts in the presence of bone 94 morphogenetic protein (BMP)-2 and is commonly used in osteoinduction studies [21] [22] [23] [24] [25] . 95 MC3T3-E1 subclone 4 cells (ATCC ® CRL2593™) were chosen as a second cell line for 96 testing of the scaffold's osteoinductive potential. These cells are an osteoblast precursor 97 derived from C57BL/6 mice and previously used to study osteoinductive potential 26, 27 . 98
In Vitro 99

Scaffolds or cancellous DBM sheets (Musculoskeletal Transplant Foundation, 100
Edison NJ) (n=77 per group) were seeded with 1x10 6 C2C12 cells. As a negative control, 101 cells were also seeded onto gelfoam sponges (Cardinal Health) which have very limited 102 biologic activity. The C2C12 cell line was passaged in DMEM supplemented with 103 penicillin/streptomycin and 10% FBS, never exceeding 80% confluence in order to avoid 104 terminal differentiation and myoblastic depletion. Cells were harvested at passage 4 and 105 suspended in 100 µL aliquots before being seeded onto constructs. Constructs were moved 106 into Petri dishes covered with media and incubated for 24 hours to allow cell attachment 107 to the matrix.. After 24 hours of incubation Samples from each group (n=11) were taken 108 for analysis while the remaining were separated for continued incubation in 2 different 109 medias: 1) Osteogenic Media (OM) 28 The alkaline phosphatase (ALP) enzyme activity was measured from constructs 142 (n=3) using methods previously described. 36, [38] [39] [40] [41] [42] Each reaction was read in triplicate by 143 loading 150 µL from each tube into 96 well plates and measuring absorbance at 405 nm on 144 a microplate reader (Spectra Max 340 PC). Cell-specific ALP activity was determined by 145 normalizing enzyme activity to the respective sample's DNA content determined by Pico 146 Green assay. 38, 43, 44 formation within the scaffold (Figure 9 ). IHC analysis revealed positive staining for OPN 229 and ALP. These results proved that the scaffold maintains osteoinductive properties 230 following decellularization, due to its ability to recruit and stimulate cells down a bone 231 forming lineage in vivo. 232
Discussion 233
Large bone defects resulting from trauma, infection, or tumor resection often require 234 bone grafting to fill the defect 1, 7 . The gold standard for bone grafting is autologous bone 235 graft; however, limited quantity and structural deficiencies preclude its use in larger 236 defects. Allograft is a suitable alternative, but this has been associated with the 237 transmission of infectious diseases 7, 8 . Additionally, the quantity of donor bone is limited, 238 and donor biology cannot be controlled, resulting in considerable variability in graft 239 quality 8 . Therefore, tissue engineering plays an increased role in developing 240 alternatives 48, 49 . One possibility is the use of xenografts. Our laboratory established a novel decellularization and oxidation technique using peracetic acid that removes 98% of 242 DNA when applied to porcine bone 20 . Our current study demonstrates that this treatment 243 protocol preserves at least some of the native porcine bone's osteoinductive potential in 244 the decellularized scaffold. In vitro results were comparable to demineralized bone 245 matrix, a commercial product currently in clinical use with proven osteoinductive 246 potential. 247
There are limitations to our study. First, clinical translation of in vitro and animal 248 experiments is limited. However, we believe these experiments were a necessary first 249 step to determine the properties of this bone scaffold after undergoing the 250 decellularization and oxidation procedure. Second, our in vivo experiments involve an 251 ectopic subcutaneous implantation model, rather than an orthotopic bone void filling 252 model. However, the purpose of these experiments was solely to determine the 253 osteoinductive potential of this scaffold in an in vivo environment. Additionally, RNA 254 collection may have been limited due to the porous nature of the scaffold. However, we 255 attempted to minimize this by vigorous agitation of the scaffold for 30 minutes. Finally, a 256 major limitation is the use of murine rather than human cell lines for these experiments, 257 which limits immediate clinical translation. These cell lines, however, have been 258 validated for study of biomaterials osteoinductive potential previously 50, 51 . The use of 259 murine cells also permitted the analysis of immune reactivity and scaffold rejection, 260 which did not occur in our study. 261 BMP-2 is one of the strongest stimulants of osteogenic differentiation in the pre-262 osteoblast cell lines used in our experiments 22,23,37,51-53 . Concentrations as low as 100 263 ng/mL and 50 ng/mL were sufficient to promote osteogenic differentiation with increased 264 ALP activity in MC3T3-E1 53 and C2C12 22 , respectively. However, few reports studied 265 osteogenic differentiation of cells seeded onto xenograft derived bone 266 scaffolds 38, 40, 43, 44, 54 . Hashimoto et al. 43 demonstrated that porcine hydroxyapatite contains 267 osteoinductive properties and that these properties are maintained after processing 43 . 268 Similarly, Smith et al. 55 found that the osteoinductive properties were maintained in 269 allografts following a decellularization and washing procedure. However, Bormann et 270 al. 37 used a similar decellularization and oxidation protocol to ours with the addition of 271 peracetic acid on allograft specimens and found that the osteoinductive potential was not 272 maintained. In the present study, we applied a novel decellularization and oxidation 273 technique using peracetic acid that removed 98% of the porcine DNA from the bone 274 scaffolds 20 . Contrary to the findings by Boorman et al. 37 , our results demonstrate that the 275 xenograft does indeed maintain osteoinductive potential after processing. C2C12 and 276 MC3T3-E1 cells attached to the scaffold matrix, proliferated, and underwent osteogenic 277 differentiation during the incubation period. The discrepancy between these studies 278 outlines the variability between decellularization techniques as well as allograft 279 specimens. Bormann et al. 37 reported that the donors for the samples used ranged in age 280 from 13-67 years old, and gender could be a source of variability between samples. These 281 discrepancies may affect osteoinductive capacity 56 Overall, our data demonstrate that a novel decellularization and oxidation 298 technique applied to porcine metaphyseal bone preserves the osteoinductive nature of the 299 bone. Previous literature identifies that these properties are the most difficult to 300 artificially create in synthetic scaffolds and to maintain when processing bone scaffolds, 301 therefore outlining the potential clinical impact of this construct. Future studies involving 302 this xenograft will focus on placing the construct within a bone defect, identifying 303 osseointegration, and comparing it to current standard treatments. These experiments will 304 look at the effect of supplementing the scaffold with human mesenchymal stem cells, as a 305 step towards clinical translation. Furthermore, an in vivo analysis of inflammatory 306 markers to confirm that the bone scaffold has no increased reactivity when compared to 307 currently used clinical implants for large bone defects should be performed. 308
Legends Figure 1. Live/Dead Stained Confocal Microscopy Images
Demineralized Bone Matrix (DBM), scaffold, and gelfoam matrices were seeded with 1 million C2C12 pre-osteoblast cells and incubated to select time points. Cross sectional images were captured at 10x magnification and overlayed to create the shown 3d projections. On day 1, matrices were switched into osteogenic media (OM) enriched with 100 ng/ml BMP-2. Representative micrographs show green fluorophore (calcein AM) staining of live cells and red fluorophore (ethidium) staining of dead cells. Constructs had notable autofluorescence with ethidium staining as shown in the "blank" images. Cell density increased with time on all 3 matrices, consistent with DNA quantification results. . Alkaline Phosphatase Immunohistochemistry ALP immunohistochemical staining increased at day 15 in both constructs, confirming that there is increased alkaline phosphatase activity that is similar between constructs.
Figure 7. Gene Expression of Osteogenic Factors
Gene expression of ALP (A; Alk Phos), bone morphogenetic protein (BMP) -2 (B), and BMP-7 (C) is increased in scaffolds pre-seeded with cells when compared to scaffolds with no cells. However, only alkaline phosphatase reached significance.
Figure 8. MicroCT Analysis of in vivo Constructs
Bone volume ratio and trabecular thickness both increase between pre-implantation and explantation (p=0.0013 and p=0.0002, respectively) signifying new bone formation within the xenograft. 
